Molecular Characterization of Syndromic Hearing Loss in North African Moroccan Families
Biomolecules · 22.04.2026 · 16 (5) · 619
DOI: 10.3390/biom16050619 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomolecules, online erschienen am 22.04.2026. Verfasst von Khawla El Fizazi und 7 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Biomedical and Translational Research, Faculty of Medicine, Pharmacy and Dentistry, Sidi Mohamed Ben Abdellah University, Fez 30000, Mo…. Hauptthemen laut MEDLINE: Hearing Loss. Die Arbeit nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIDCD NIH HHS, NIDCD/NIH.
Abstract (Originalsprache)
Hearing loss (HL) is a common sensory disorder, with syndromic forms accounting for ~30% of genetic cases. Due to phenotypic and genetic heterogeneity, accurate diagnosis remains challenging. Exome sequencing (ES) offers a powerful tool to uncover the underlying genetic causes. This study aimed to investigate the genetic basis of syndromic hearing loss (SHL) in North African Moroccan patients through ES. Seven individuals with suspected SHL were recruited from Hassan II University Hospital, Fez. After clinical and audiological assessments, ES was performed to identify causal genetic variants. Two of the participating individuals had Usher syndrome, and one each had Cornelia de Lange syndrome, Wolfram syndrome, Jervell and Lange-Nielsen syndrome, CHARGE syndrome, and Waardenburg syndrome. The causes of all these syndromes were determined, with pathogenic variants in MYO7A, USH1G, SMC1A, WFS1, KCNQ1, CHD7, and MITF. Across the combined cohort of reported Moroccan SHL cases, variants in CHD7 and MYO7A were among the most frequently observed, while USH1G and MITF variants were rare. This study enhances the understanding of SHL in North Africa, revealing a high level of locus and allelic heterogeneity. Examining disparate populations yields novel insights into the etiology of SHL, which can subsequently enhance genetic diagnosis and tailored management strategies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory of Biomedical and Translational Research, Faculty of Medicine, Pharmacy and Dentistry, Sidi Mohamed Ben Abdellah University, Fez 30000, Morocco.
- Unit of Medical Genetics and Oncogenetics, Hassan II University Hospital, Fez 30050, Morocco.
- Department of Otorhinolaryngology-Head & Neck Surgery, University of Maryland, Baltimore, MD 21201, USA.
- Department of Biochemistry and Molecular Biology, University of Maryland, Baltimore, MD 21201, USA.
- Marlene & Stewart Greenebaum Comprehensive Cancer Center, University of Maryland, Baltimore, MD 21201, USA.
- Department of Otorhinolaryngology, Hassan II University Hospital, Fez 30050, Morocco.
ORCID-Profile: Zubair M Ahmed
Förderung
- NIDCD NIH HHS
- NIDCD/NIH
Zitieren
APA
El Fizazi, K., Ghaffar, A., Bouguenouch, L., Saleem, I. B., Ouldim, K., Ahmed, Z. M., Ridal, M., & Riazuddin, S. (2026). Molecular Characterization of Syndromic Hearing Loss in North African Moroccan Families. Biomolecules, 16(5), 619. https://doi.org/10.3390/biom16050619
Vancouver
El Fizazi K, Ghaffar A, Bouguenouch L, Saleem IB, Ouldim K, Ahmed ZM, et al. Molecular Characterization of Syndromic Hearing Loss in North African Moroccan Families. Biomolecules. 2026;16(5):619. doi:10.3390/biom16050619
BibTeX
@article{ElFizazi2026,
author = {El Fizazi, Khawla and Ghaffar, Amama and Bouguenouch, Laila and Saleem, Irum Badshah and Ouldim, Karim and Ahmed, Zubair M and Ridal, Mohammed and Riazuddin, Saima},
title = {Molecular Characterization of Syndromic Hearing Loss in North African Moroccan Families},
journal = {Biomolecules},
year = {2026},
volume = {16},
number = {5},
pages = {619},
doi = {10.3390/biom16050619}
}
EUVIMED